The British Journal of Dermatology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Why do we distinguish between virus-positive and virus-negative Merkel cell carcinoma?
Br J Dermatol. 2024 Feb 23:ljae086. doi: 10.1093/bjd/ljae086. Online ahead of print.NO ABSTRACTPMID:38391034 | DOI:10.1093/bjd/ljae086 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - February 23, 2024 Category: Dermatology Authors: Furkan Bahar James A DeCaprio Source Type: research

Dealing with Flares in Skin Conditions: How Can We Meet Patient Need?
Br J Dermatol. 2024 Feb 23:ljae084. doi: 10.1093/bjd/ljae084. Online ahead of print.NO ABSTRACTPMID:38390937 | DOI:10.1093/bjd/ljae084 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - February 23, 2024 Category: Dermatology Authors: Olivia Hughes Andrew R Thompson Source Type: research

Failure of second challenge with Mogamulizumab in CCR4-positive cutaneous T-cell lymphoma
Br J Dermatol. 2024 Feb 23:ljae085. doi: 10.1093/bjd/ljae085. Online ahead of print.NO ABSTRACTPMID:38390970 | DOI:10.1093/bjd/ljae085 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - February 23, 2024 Category: Dermatology Authors: Romain Stammler Van Anh Ta Elisabeth Cohen Caroline Ram-Wolff Aliz ée Bozonnat Gilles Battesti Baptiste Louveau Samia Mourah Maxime Battistella H élène Moins-Teisserenc Ad èle de Masson Source Type: research

Correction to: How to recognize and manage skin toxicities associated with immune checkpoint inhibitors: a practical approach
Br J Dermatol. 2024 Feb 21:ljae060. doi: 10.1093/bjd/ljae060. Online ahead of print.NO ABSTRACTPMID:38381599 | DOI:10.1093/bjd/ljae060 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - February 21, 2024 Category: Dermatology Source Type: research

Prediction, screening and characterization of novel bioactive tetra-peptide matrikines for skin rejuvenation
CONCLUSIONS: We conclude that this approach to peptide discovery and testing can identify new synthetic matrikines, providing insights into biological mechanisms of tissue homeostasis and repair and new pathways to clinical intervention.PMID:38375775 | DOI:10.1093/bjd/ljae061 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - February 20, 2024 Category: Dermatology Authors: Nathan Jariwala Matiss Ozols Alexander Eckersley Bezaleel Mambwe Rachel E B Watson Leo Zeef Andrew Gilmore Laurent Debelle Mike Bell Eleanor J Bradley Yegor Doush Amy Keenan Carole Courage Richard Leroux Olivier Peschard Philippe Mondon Caroline Ringenbac Source Type: research

A guide to improving the design and analysis of observational studies on the long-term safety of topical corticosteroids
Br J Dermatol. 2024 Feb 16:ljae065. doi: 10.1093/bjd/ljae065. Online ahead of print.NO ABSTRACTPMID:38366624 | DOI:10.1093/bjd/ljae065 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - February 17, 2024 Category: Dermatology Authors: Aaron M Drucker Peter C Austin Jane Harvey Stephanie J Lax Mina Tadrous Kim S Thomas Source Type: research

Intravenous gentamicin therapy induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients: An open label clinical trial
CONCLUSIONS: IV gentamicin induced readthrough of nonsense mutations in RDEB patients and restored functional C7 in their skin, enhanced wound healing, and improved clinical parameters. IV gentamicin may be a safe, efficacious, low cost, and readily available therapy in this population of RDEB patients.TRIAL REGISTRATION: Clinicaltrials.gov Identifiers: NCT03392909.PMID:38366625 | DOI:10.1093/bjd/ljae063 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - February 17, 2024 Category: Dermatology Authors: David T Woodley Michelle Hao Andrew Kwong Brandon Levian Jon Cogan Yingping Hou Daniel Mosallaei Elana Kleinman Kate Zheng Claire Chung Gene Kim David Peng Mei Chen Source Type: research

Cancer Type and Histology Influence Cutaneous Immunotherapy Toxicities: A Multi-Institutional Cohort Study
CONCLUSIONS: The highest rate of cirAEs and subsequent survival benefits were observed in cutaneous malignancies treated with ICIs. This study improves our understanding of patients who are at highest risk of developing cirAEs and would, therefore, benefit from appropriate counseling and closer monitoring by their oncologists and dermatologists throughout their ICI therapy. Limitations include its retrospective nature and cohort from one geography.PMID:38366637 | DOI:10.1093/bjd/ljae053 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - February 17, 2024 Category: Dermatology Authors: Guihong Wan Sara Khattab Bonnie W Leung Shijia Zhang Nga Nguyen Matthew Tran Chuck Lin Crystal Chang Nora Alexander Ruple Jairath Jordan Phillipps Kimberly Tang Ahmad Rajeh Leyre Zubiri Steven T Chen Shadmehr Demehri Kun-Hsing Yu Alexander Gusev Shawn G K Source Type: research

A multicenter, randomized, double-blinded, placebo-controlled, phase Ⅲ study evaluating the efficacy and safety of Xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis
CONCLUSION: Xeligekimab showed high efficacy and is well tolerated in Chinese patients with moderate-to-severe plaque psoriasis.PMID:38366639 | DOI:10.1093/bjd/ljae062 (Source: The British Journal of Dermatology)
Source: The British Journal of Dermatology - February 17, 2024 Category: Dermatology Authors: Lin Cai Congjun Jiang Guoqiang Zhang Hong Fang Jinyan Wang Yumei Li Hui Xu Rong Xiao Yangfeng Ding Kun Huang Chunlei Zhang Litao Zhang Bin Chen Xinsuo Duan Weili Pan Guangming Han Rongyi Chen Lunfei Liu Shoumin Zhang Juan Tao Xiaowen Pang Jianbin Yu Huipi Source Type: research